ResearcherFred and Pamela Buffett Cancer CenterNo recent work listed
Parama Dey
Matched on ORCID iD 0000-0003-3529-7062; OpenAlex author ID A5006114608. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 27
2011: 1 paper · 2012: 2 papers · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper
Papers 7
- Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.6580↗
- Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model. Co-author DOI 10.18632/oncotarget.5641↗
- Novel role of pancreatic differentiation 2 in facilitating self-renewal and drug resistance of pancreatic cancer stem cells. Co-author DOI 10.1038/bjc.2014.152↗
- Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology. Co-author DOI 10.5858/arpa.2011-0229-oa↗
- Overexpression of ecdysoneless in pancreatic cancer and its role in oncogenesis by regulating glycolysis. Co-author DOI 10.1158/1078-0432.ccr-12-1789↗
- Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy. Co-author DOI 10.1186/1756-8722-5-68↗
- Human RNA polymerase II-association factor 1 (hPaf1/PD2) regulates histone methylation and chromatin remodeling in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0026926↗
Closest collaborators
The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Surinder K. Batra · 7 shared papers, 2011–2016 · strength 0.29
- Paper Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered… DOI 10.18632/oncotarget.5641↗
- Paper Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma. DOI 10.18632/oncotarget.6580↗
- Paper Novel role of pancreatic differentiation 2 in facilitating self-renewal and drug resistance of pancreatic cancer stem c… DOI 10.1038/bjc.2014.152↗
- Satyanarayana Rachagani · 5 shared papers, 2012–2016 · strength 0.21
- Paper Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered… DOI 10.18632/oncotarget.5641↗
- Paper Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma. DOI 10.18632/oncotarget.6580↗
- Paper Novel role of pancreatic differentiation 2 in facilitating self-renewal and drug resistance of pancreatic cancer stem c… DOI 10.1038/bjc.2014.152↗
- Moorthy Palanimuthu Ponnusamy · 4 shared papers, 2011–2016 · strength 0.17
- Paper Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma. DOI 10.18632/oncotarget.6580↗
- Paper Novel role of pancreatic differentiation 2 in facilitating self-renewal and drug resistance of pancreatic cancer stem c… DOI 10.1038/bjc.2014.152↗
- Paper Human RNA polymerase II-association factor 1 (hPaf1/PD2) regulates histone methylation and chromatin remodeling in panc… DOI 10.1371/journal.pone.0026926↗
- Subodh M. Lele · 3 shared papers, 2012–2016 · strength 0.12
- Paper Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma. DOI 10.18632/oncotarget.6580↗
- Paper Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle… DOI 10.5858/arpa.2011-0229-oa↗
- Paper Overexpression of ecdysoneless in pancreatic cancer and its role in oncogenesis by regulating glycolysis. DOI 10.1158/1078-0432.ccr-12-1789↗
- Lynette M. Smith · 2 shared papers, 2015–2016 · strength 0.10
- Paper Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered… DOI 10.18632/oncotarget.5641↗
- Paper Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma. DOI 10.18632/oncotarget.6580↗
- Arokia Priyanka Vaz · 2 shared papers, 2014–2016 · strength 0.10
- Muzafar Ahmad Macha · 2 shared papers, 2012–2015 · strength 0.08
- Paper Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered… DOI 10.18632/oncotarget.5641↗
- Paper Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diag… DOI 10.1186/1756-8722-5-68↗
- Subhankar Chakraborty · 2 shared papers, 2012–2013 · strength 0.07
- Paper Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle… DOI 10.5858/arpa.2011-0229-oa↗
- Paper Overexpression of ecdysoneless in pancreatic cancer and its role in oncogenesis by regulating glycolysis. DOI 10.1158/1078-0432.ccr-12-1789↗
- Dhanya Haridas · 2 shared papers, 2012–2013 · strength 0.07
- Paper Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle… DOI 10.5858/arpa.2011-0229-oa↗
- Paper Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diag… DOI 10.1186/1756-8722-5-68↗
- Priya Pai · 1 shared paper, 2015 · strength 0.05
- Yin‐Yuan Mo · 1 shared paper, 2015 · strength 0.05
- Saswati Karmakar · 1 shared paper, 2016 · strength 0.05
- Sakthivel Muniyan · 1 shared paper, 2016 · strength 0.05
- Imayavaramban Lakshmanan · 1 shared paper, 2016 · strength 0.05
- Michel M. Ouellette · 1 shared paper, 2016 · strength 0.05
- Apar Kishor Ganti · 1 shared paper, 2014 · strength 0.05
- Adam J. Horn · 1 shared paper, 2013 · strength 0.04
- Joshua J. Souchek · 1 shared paper, 2013 · strength 0.04
- Pankaj Kumar Singh · 1 shared paper, 2012 · strength 0.03
- Michael Anthony Hollingsworth · 1 shared paper, 2012 · strength 0.03
- María P. Torres · 1 shared paper, 2012 · strength 0.03
- Parthasarathy Seshacharyulu · 1 shared paper, 2012 · strength 0.03
- Sukhwinder Kaur · 1 shared paper, 2012 · strength 0.03
- Kay‐Uwe Wagner · 1 shared paper, 2012 · strength 0.03
- Maneesh Jain · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.